An Electrochemical Impedance Biosensor Based on Hybrid Nanomaterial UiO-66@Au NPs @FA for Label-Free and Sensitive Detection of Endometrial Cancer Cells

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058608

Enrollment

Unknown

Registered

2022-04-12

Start date

2022-04-12

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

test group:None

control group:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients undergoing total hysterectomy. 2.Agree to participate in this study and sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Acute inflammation of the reproductive system (except atrophic vaginitis); 2. Patients with malignant tumors other than endometrial cancer such as cervical cancer and ovarian cancer; 3. Patients with abnormal coagulation function and other blood system diseases that affect coagulation; 4. The amount of bleeding is large, and emergency curettage is needed to stop the bleeding; 5. Those whose body temperature exceeds 37.5? twice on the day of treatment.

Design outcomes

Primary

Measure	Time frame
Impedance change;Age;Sensitivity of sensor;Specificity of sensor;Accuracy of sensor;Detection limit of sensor;Detection range of sensor;	—

Countries

China

Contacts

Public ContactQiling Li

The First Affiliated Hospital of Xi'an Jiaotong University

liqiling@mail.xjtu.edu.cn+86 18991232838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026